Literature DB >> 11872958

Overexpression of sialyl Lewis x antigen is associated with formation of extratumoral venous invasion and predicts postoperative development of massive hepatic metastasis in cases with pancreatic ductal adenocarcinoma.

S Takahashi1, T Oda, T Hasebe, S Sasaki, T Kinoshita, M Konishi, T Ueda, C Nakahashi, T Ochiai, A Ochiai.   

Abstract

The clinicopathological factors and expression of sialyl Lewis antigens which are the cell adhesion molecules to endothelial cells were compared in relation to the extent of the postoperative hepatic metastasis in 23 consecutive patients with pancreatic ductal adenocarcinoma whose clinical courses were carefully monitored and documented. The overall survival of cases with massive hepatic metastasis (MHM) was significantly poorer than that of those with local or no hepatic metastasis (p = 0.0453). Postoperative MHM was significantly correlated with the presence of duodenal invasion (p = 0.0418), the presence of portal vein invasion (p = 0.0435), the presence of extratumoral venous invasion (p = 0.0052) and high expression of sialyl Lewis x antigen (p = 0.0022). Multivariate analysis confined significant correlation between the high expression of sialyl Lewis x antigen and the development of MHM (p = 0.0402). Kaplan-Meier analysis revealed that the overall survival of patients with a high expression of sialyl Lewis x antigen was significantly poorer than that of patients with a low expression of the antigen (p = 0.0216). These results indicate that the overexpression of sialyl Lewis x antigen plays an important role in the development of MHM, and also predicts a poorer overall survival of these patients. Further studies with more cases are warranted to confirm these results. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11872958     DOI: 10.1159/000048767

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  15 in total

1.  Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms.

Authors:  Brian B Haab; Andrew Porter; Tingting Yue; Lin Li; James Scheiman; Michelle A Anderson; Dawn Barnes; C Max Schmidt; Ziding Feng; Diane M Simeone
Journal:  Ann Surg       Date:  2010-05       Impact factor: 12.969

2.  Sialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells.

Authors:  Matthew R Dallas; Shih-Hsun Chen; Mirte M Streppel; Sidharth Sharma; Anirban Maitra; Konstantinos Konstantopoulos
Journal:  Am J Physiol Cell Physiol       Date:  2012-07-18       Impact factor: 4.249

3.  Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins.

Authors:  Benjamin F Mann; John A Goetz; Michael G House; C Max Schmidt; Milos V Novotny
Journal:  Mol Cell Proteomics       Date:  2012-03-05       Impact factor: 5.911

4.  Mucin 16 is a functional selectin ligand on pancreatic cancer cells.

Authors:  Shih-Hsun Chen; Matthew R Dallas; Eric M Balzer; Konstantinos Konstantopoulos
Journal:  FASEB J       Date:  2011-12-09       Impact factor: 5.191

5.  Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells.

Authors:  Yi-Mi Wu; D David Nowack; Gilbert S Omenn; Brian B Haab
Journal:  J Proteome Res       Date:  2009-04       Impact factor: 4.466

6.  Transgene expression of alpha(1,2)-fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin.

Authors:  Sylvie Mathieu; Maëlle Prorok; Anne-Marie Benoliel; Rathviro Uch; Claire Langlet; Pierre Bongrand; René Gerolami; Assou El-Battari
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

7.  Clinicopathological and prognostic significance of sialyl Lewis X overexpression in patients with cancer: a meta-analysis.

Authors:  Jin-Xiao Liang; Yong Liang; Wei Gao
Journal:  Onco Targets Ther       Date:  2016-05-24       Impact factor: 4.147

Review 8.  Altered tumor-cell glycosylation promotes metastasis.

Authors:  Irina Häuselmann; Lubor Borsig
Journal:  Front Oncol       Date:  2014-02-13       Impact factor: 6.244

9.  Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.

Authors:  Seema Chugh; Jane Meza; Yuri M Sheinin; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Br J Cancer       Date:  2016-05-17       Impact factor: 7.640

10.  Glycans related to the CA19-9 antigen are elevated in distinct subsets of pancreatic cancers and improve diagnostic accuracy over CA19-9.

Authors:  Huiyuan Tang; Katie Partyka; Peter Hsueh; Jessica Y Sinha; Doron Kletter; Herbert Zeh; Ying Huang; Randall E Brand; Brian B Haab
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.